Rise in number of cancer patients has led to rise in investments from government to establish specialized hospitals, which is expected to drive market revenue growth
Rise in number of cancer patients has led to rise in investments from government to establish specialized hospitals, which is expected to drive market revenue growth
The global cancer biomarkers market size was USD 27.83 Billion in 2021, and is expected to register a revenue CAGR of 17.6% during the forecast period. Rapid implementation of advanced technologies for cancer biomarker detection and development, and rising investments towards Research & Development (R&D) activities for detection of various cancer biomarkers are major factors expected to drive the market revenue growth.
Biomarkers plays a crucial role in identifying the presence of cancer within the body. It also helps in identifying the intensity to which cancer has spread within the body. A biomarker is a biological molecule found in blood, other body fluids, or tissues and signals a normal or abnormal process, or of a condition or disease. Increasing R&D in laboratories has led to introduction of new biomarkers for identifying specific cancers. Rise in number of cancer patients across the globe has led to a demand for better diagnostic techniques. If a patient is diagnosed early and has been confirmed with cancer, then it becomes easy for doctors to treat him or her well. Biomarkers help in detecting cancer at an early stage via different profiling technologies. Rise in awareness programs for early diagnosis of cancer has also led to increase in demand of profiling technologies.
Biomarkers help in identifying the presence of tumor cells within the body with a high efficacy rate instead of going through large number of tests. During diagnosis, if biomarker is used for identifying the cancer then it can reduce the cost of testing. Low cost, easily accessibility and quick results are certain benefits of using biomarkers for diagnosing cancer, which is expected to drive market revenue growth.
Access Free sample PDF Copy of the Report @ https://www.reportsanddata.com/sample-enquiry-form/1422
Some Key Highlights from the Report
- By biomolecule type, proteomic segment accounted for the largest revenue share in 2020. Proteomics field has seen immense development over the past few years. Technological advancements in the field have facilitated enhancement of sample multiplexing ability, identification of protein interactions and sensitivity. Proteomic biomarker technologies have the potential to analyze multiple proteins, and such technologies include mass spectrometry and protein microarray.
- By application, prognostics segment accounted for largest market revenue share in 2020. Biomarkers in cancer treatment can be used for disease prognosis which takes place after an individual has been diagnosed with cancer. Biomarkers can be useful in determining the aggressiveness of an identified cancer as well as its likelihood of responding to a given treatment. Prognostic biomarker include elevated levels of metallopeptidase inhibitor 1(TIMP1), a marker associated with more aggressive forms of multiple myeloma and many more. Prognosis helps in complete removal of cancer cells within the body, and thus such an application is expected to drive the segment revenue growth.
- Cancer Biomarker Market in North America accounted for largest revenue share in 2020. The region has an extremely advanced healthcare sector, which engages itself in continuous R&D activities for innovative product launches. The region serves as the headquarters for a plethora of key players operating in the market. Countries in this region have high incidence rate of cancer, consequently leading to an escalating demand for novel as well as effective therapeutic modalities.
- Cancer biomarkers market in the Asia Pacific region is expected to register a faster revenue CAGR during the forecast period due to rapid healthcare infrastructural developments, increasing technological developments and expansion of the R&D activities in the region. Countries such as India and China have untapped potential, which is further expected to drive the developments in the regional market.
- In January 2022, Thermo Fisher Scientific Inc. and PeproTech Inc. announced that Thermo Fisher Scientific had completed its acquisition of PeproTech. PeproTech is a privately held provider of bioscience reagents known as recombinant proteins, including cytokines and growth factors. Recombinant proteins are used in the development and manufacturing of cell and gene therapies as well as in broader cell culture applications, especially for use in cellular research models.
- Companies profiled in the global market report include Abbott Laboratories Ltd., Celera Corporation, Thermo Fisher Scientific Inc., Bio-Rad Laboratories Inc., F. Hoffmann-La Roche Ltd., Illumina Inc., GE Healthcare Systems, Becton, Dickson & Company, Quest Diagnostics Inc., Genomic Health, Inc., and Hologic Inc.
Get In detailed Research Study @ https://www.reportsanddata.com/report-detail/cancer-biomarkers-market
For the purpose of this report, Reports and Data has segmented the Cancer Biomarker Market based on biomolecule type, profiling technologies, services, diseases type, application, and region:
Biomolecule Type Outlook (Revenue, USD Million; 2018–2030)
- Genetic
- Epigenetic
- Proteomic
- Glycoprotein
Profiling Technologies Outlook (Revenue, USD Million; 2018–2030)
- Imaging Technologies
- OMIC Technologies
- Cytogenetics based tests
- Immunoassays
- Bioinformatics
Services Outlook (Revenue, USD Million; 2018–2030)
-
- Sample Preparation
- Assay Development
- Biomarkers and Testing
Diseases Type Outlook (Revenue, USD Million; 2018–2030)
-
- Breast Cancer
- Blood Cancer
- Lung Cancer
- Cervical Cancer
- Colorectal Cancer
- Melanoma
- Ovarian Cancer
- Liver Cancer
- Stomach Cancer
- Others
Application Outlook (Revenue, USD Million; 2018–2030)
-
- Risk Assessment
- Prognostics
- Diagnostics
- Personalized Medicine
- Others Applications
Buy Premium Research Report @ https://www.reportsanddata.com/report-pricing/1422
Regional Outlook (Revenue, USD Million; 2018–2030)
-
- North America
- U.S.
- Canada
- Mexico
- Europe
- Germany
- U.K.
- France
- Italy
- Spain
- Sweden
- BENELUX
- Rest of Europe
- Asia Pacific
- China
- India
- Japan
- South Korea
- Rest of APAC
- Latin America
- Brazil
- Rest of LATAM
- Middle East & Africa
- Saudi Arabia
- UAE
- South Africa
- Israel
- Rest of MEA
- North America
Ask for Customize Research Report @ https://www.reportsanddata.com/request-customization-form/1422
Some points on how the report benefits stakeholders:
- The reports include historical (2018–2020) and forecast (2021–2030) data points, revenues, and CAGR in table, figure, and chart formats, with detailed and qualitative, supporting written information for each.
- Revenue break-up is provided for each segment in these formats for global, regional, and for each country in the respective region for each year between 2018 and 2030.
- The report contains insights regarding growth drivers, restraints, opportunities, trends, company profiles, strategic developments, expansion details, product launches, and various other aspects related to the market.
- The report contains data and information on customers, competitors, vendors/distributors, and other players and in the global marketplace.
- Market research analysis is vital for all crucial business strategies and can aid in numerous ways and to provide a clearer understanding about strategies being deployed by competitors, product launches, competitive analysis, technological advancements and various other factors that enhance sales of a firm or perhaps provide insights to focus on merger and acquisition as a strategy or enter into strategic agreements or joint ventures etc.
- The report contains company profiles of the top companies operating in the market along with their respective revenue and operating segments, geographical reach, market footprint, headquarters, growth rates, recent developments, product /services, expansion strategies, investments in expansion, and more.
Explore Latest Trending Research Reports By Reports and Data’s
Blood Pressure Monitoring Device Market Size, Share And Industry Analysis By Product Type (Aneroid BP Monitors, Digital BP Monitors, Blood Pressure Instrument Accessories, Sphygmomanometers, and Others), By End-Use (Hospitals and Clinics, Ambulatory Surgical Centers, Home Settings, and Others), and By Region Forecast to 2028
Surgical Needle Market By Product Type (Eyed Needle, Eyeless Needle/Swage), By Shape (Straight Shaped Needles, J Shape Needles, Compound Curve-shaped Needles, Half Curved), By End-use (Ambulatory Surgical Centers, Hospitals & Clinics, Others), and By Region Forecast to 2028
Topical Corticosteroids Market By Medication Type (Ointments, Creams, Lotions, Gel, Pastes, Sprays, Others), By Application (Acne, Dermatitis, Psoriasis, Skin Infection, Hyperpigmentation, Melasma, Others), By Distribution Channel (Hospital Pharmacies, Pharmacy Stores, Online Pharmacies, Others), By End-use (Hospitals, Dermatology Clinics, Pharmacies, Others), and By Region Forecast To 2028
Incontinence Devices Market By Incontinence Type (Urinary Incontinence, Fecal Incontinence), By Devices (Pessary, Urine Seal, Urethral Insert, Bladder Neck Support Device, Artificial Urinary Sphincter, Other Devices), By End User (Hospitals, Ambulatory Surgical Centres, Others), and By Region Forecast to 2028
About Reports and Data
Reports and Data is a market research and consulting company that provides syndicated research reports, customized research reports, and consulting services. Our solutions purely focus on your purpose to locate, target, and analyze consumer behavior shifts across demographics, across industries, and help clients to make smarter business decisions. We offer market intelligence studies ensuring relevant and fact-based research across multiple industries, including Healthcare, Touch Points, Chemicals, Products, and Energy. We consistently update our research offerings to ensure our clients are aware of the latest trends existent in the market. Reports and Data has a strong base of experienced analysts from varied areas of expertise. Our industry experience and ability to develop a concrete solution to any research problems provides our clients with the ability to secure an edge over their respective competitors.
Contact Us:
John W
Head of Business Development
Reports And Data | Web: www.reportsanddata.com
Direct Line: +1-212-710-1370
E-mail: sales@reportsanddata.com
LinkedIn | Twitter | Blogs
Read Latest Press Release @ https://www.reportsanddata.com/press-release/global-cancer-biomarkers-market